Indicator full name: Proportion (%) of tuberculosis cases cured under DOTS
- Country (COUNTRY)
- Supranational group of countries (COUNTRY_GRP)
- Sex (SEX)
- Year of measure (YEAR)
Years data is available: 1994—2006
Last updated: 22 September 2016
- United Kingdom
- WHO European Region
- Members of the European Union
- Members of the EU before May 2004 (EU15)
- Members of the EU after May 2004 (EU13)
- Commonwealth of Independent States
- Central Asian Republics Information Network members (CARINFONET)
- South-eastern Europe Health Network members (SEEHN)
- Nordic countries
- Small countries
The following abbreviations are used in the indicator titles:
The joint monitoring framework (JMF) is used for reporting on indicators under three monitoring frameworks: the Sustainable Development Goals (SDGs), Health 2020 and the Global Action Plan for the Prevention and Control of Noncommunicable Diseases (NCDs) 2013–2020. The Regional Committee for Europe adopted the JMF in September 2018.
The majority of JMF indicators in the Gateway are linked to existing databases in the Gateway.
EUR/RC68/10 Rev.1 Briefing note on the expert group deliberations and recommended common set of indicators for a joint monitoring framework
EUR/RC68(1): Joint monitoring framework in the context of the roadmap to implement the 2030 Agenda for Sustainable Development, building on Health 2020, the European policy for health and well-being
Developing a common set of indicators for the joint monitoring framework for SDGs, Health 2020 and the Global NCD Action Plan (2017)
Indicator code: E040306.T This indicator shares the definition with the parent indicator \"Estimated incidence of tuberculosis per 100 000\".
Data collection for indicator 040305: % of tuberclosis cases detected under DOTS, as well as indicator 040306: Proportion of tuberculosis cases cured under DOTS, has been discontinued.
-WHO estimates of TB incidence, prevalence and deaths are based on a consultative and analytical process; they are revised annually to reflect new information gathered through surveillance and from special studies, such as surveys of the prevalence of infection and disease. For details of estimation methods see: http://www.who.int/tb/publications/global_report/en/index.html
-TB case detection means that TB is diagnosed in a patient and is reported within the national surveillance system, and then to WHO. The case detection rate under DOTS is calculated as the number of cases notified within areas covered by DOTS programme divided by the estimated number of cases in the whole country, expressed as a percentage.
-Treatment success in DOTS programmes is the percentage of new smear-positive patients that are cured (negative on sputum smear examination), plus the percentage that complete a course of treatment, without bacteriological confirmation of cure.